|
SNX5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.572200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.920800E-01 |
| Normal-vs-Stage2 |
7.246600E-01 |
| Normal-vs-Stage3 |
5.655000E-01 |
| Normal-vs-Stage4 |
5.368400E-01 |
| Stage1-vs-Stage2 |
8.057600E-01 |
| Stage1-vs-Stage3 |
3.787200E-01 |
| Stage1-vs-Stage4 |
3.493000E-01 |
| Stage2-vs-Stage3 |
4.724200E-01 |
| Stage2-vs-Stage4 |
4.534600E-01 |
| Stage3-vs-Stage4 |
9.441800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.660800E-01 |
| Normal-vs-AfricanAmerican |
4.762000E-01 |
| Normal-vs-Asian |
6.162800E-01 |
| Caucasian-vs-AfricanAmerican |
4.390800E-01 |
| Caucasian-vs-Asian |
5.492200E-01 |
| AfricanAmerican-vs-Asian |
3.301200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.348200E-01 |
| Normal-vs-Female |
8.366000E-01 |
| Male-vs-Female |
5.144200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.350000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.552200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.375000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.640800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.416600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.534040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.284200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.797030E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.337200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.666800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.121800E-01 |
| Classical-VS-Follicular |
3.648200E-02 |
| Classical-VS-Other |
3.007400E-01 |
| Classical-VS-Normal |
3.214400E-01 |
| Tall-VS-Follicular |
9.061600E-01 |
| Tall-VS-Other |
6.677000E-01 |
| Tall-VS-Normal |
4.631200E-01 |
| Follicular-VS-Other |
7.537200E-01 |
| Follicular-VS-Normal |
3.195800E-01 |
| Other-VS-Normal |
3.457800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.085200E-01 |
| Normal-vs-N1 |
1.599820E-01 |
| N0-vs-N1 |
2.883000E-01 |
|
|
